Monoclonal antibody that specifically binds to gitr

The present invention relates to biotechnology, in particular to antibodies or antigen-binding fragments thereof, and to use thereof. More particularly, the present invention relates to monoclonal antibodies that specifically bind to GITR. The invention also relates to a nucleic acid encoding said a...

Full description

Saved in:
Bibliographic Details
Main Authors ULITIN, ANDREI BORISOVICH, SOZONOVA, ALEKSANDRA ALEKSANDROVNA, USTIUGOV, IAKOV IUREVICH, BURNYSHEVA, KSENIA MIHAILOVNA, GORDEEV, ALEKSANDR ANDREEVICH, ISHUTINOVA, ANASTASIA NIKOLAEVNA, MITROSHIN, IVAN VLADIMIROVICH, SOLOVYEV, VALERY VLADIMIROVICH, KOZLOVA, OLESYA, AGEEV, SERGEI ANDREEVICH, MOROZOV, DMITRY VALENTINOVICH, TSYMPILOV, VLADIMIR SERGEEVICH, IVANOV, ROMAN ALEKSEEVICH, DORONIN, ALEKSANDR NIKOLAEVICH
Format Patent
LanguageChinese
English
Published 01.06.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to biotechnology, in particular to antibodies or antigen-binding fragments thereof, and to use thereof. More particularly, the present invention relates to monoclonal antibodies that specifically bind to GITR. The invention also relates to a nucleic acid encoding said antibody or antigen-binding fragment thereof, an expression vector, a method for preparing said antibody, and use of said antibody in treatment of diseases or disorders associated with GITR.
Bibliography:Application Number: TW20198144110